Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter

Journal of Cell Biology

Volumn 144, Issue 2, 1999, Pages 373-384

  Beliën, Ann T J ^a,c   Paganetti, Paolo A ^b   Schwab, Martin E ^a  

^a University of Zurich Brain Research Institute   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Central nervous system; Diffuse astrocytoma; Invasion; Metalloprotease; MT1 MMP

Indexed keywords

GELATINASE A; INHIBITOR PROTEIN; MATRIX METALLOPROTEINASE; MEMBRANE ENZYME; MONOCLONAL ANTIBODY; MYELIN; PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL MIGRATION; CELL STRAIN 3T3; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; EXPLANT; GENETIC TRANSFECTION; GLIOMA CELL; MOUSE; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RAT; WHITE MATTER;

3T3 CELLS; ANIMALS; ANTIBODIES, MONOCLONAL; CELL EXTRACTS; CELL MEMBRANE; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM; ENZYME ACTIVATION; GELATINASES; GLIOBLASTOMA; GLIOMA; HUMANS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MICE; MYELIN SHEATH; NEOPLASM INVASIVENESS; OPTIC NERVE; PROTEASE INHIBITORS; RATS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033601769     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.144.2.373     Document Type: Article

References (54)

1. Amberger, V.R., P.A. Paganetti, H. Seulberger, J.A. Eldering, and M.E. Schwab. 1994. Characterization of a membrane-bound metalloendoprotease of rat C6 glioblastoma cells. Cancer Res. 54:4017-4025.
2. Amberger, V.R., T. Hensel, N. Ogata, and M.E. Schwab. 1998. Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res. 58:149-158.
3. Atkinson, S.J., T. Crabbe, S. Cowell, R.V. Ward, M,J. Butler, H. Sato, M. Seiki, J.J. Reynolds, and G. Murphy. 1995. Intermolecular autolytic cleavage can contribute to the activation of progclatinase A by cell membranes. J. Biol. Chem. 270:30479-30485.
4. Benda, M.E., J. Lightbody, G. Sato, L. Levine, and W. Sweet. 1968. Differential rat glia cell strain in tissue culture. Science. 161:370-371.
5. Berens, M.E., M.D. Rief, M.A. Loo, and A. Giese. 1994. The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. Clin. Exp. Met. 12:405-415.
6. Bindal, A.K., M. Hammoud, S.W. Ming, S.Z. Wu, R. Sawaya, and J.S. Roa. 1994. Prognostic significance of proteolytic enzymes in human brain tumors. J. Neuro. Oncol. 22:101-110.
7. Birkedal-Hansen, H., W.G. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J.A. Engler. 1993. Matrix metalloproteinases: a review. Crit. Rev. Oral. Biol. Med. 4:197-250.
8. Burger, P.C., E.R. Heinz, T. Shibata, P. Kleihues. 1988. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J. Neurosurgery. 68:698-704.
9. Butler, G.S., M.J. Butler, S.J. Atkinson, H. Will, T. Tamura, S.S. van Westrum, T. Crabbe, J. Clements, M.P. d'Ortho, and G. Murphy. 1998. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J. Biol. Chem. 273:871-880.
10. Caroni, P., and M.E. Schwab. 1988. Two membrane protein fractions from rat central nervous system myelin with inhibitory properties for neurite growth and fibroblast spreading. J. Cell Biol. 106:1281-1288.
11. Deryugina, E.I., M.A. Bourdon, G. Luo, R.A. Reisfeld, and A. Strongin. 1997. Matrix-metalloproteinase-2 activation modulates glioma cell migration. J. Cell. Sci. 110:2473-2482.
12. Giese, A., L. Kluwe, B. Laube, H. Meissner, M.E. Berens, and M. Westphal. 1996. Migration of human glioma cells on myelin. Neurosurgery. 38:755-764.
13. Gilles, C., M. Polette, J. Piette, C. Munaut, E.W. Thompson, P. Birembaut, and J.M. Foidart. 1996. High levels of MT1-MMP expression is associated with invasiveness of cervical cancer cells. Int. J. Cancer. 65:209-213.
14. Goldberg, W.J., E.R. Laws, Jr., and J.J. Bernstein. 1991. Individual C6 glioma cells migrate in adult rat brain after neural homografting. Int. J. Dev. Neurosci. 9:427-437.
15. Hensel, T., V.R. Amberger, and M.E. Schwab. 1998. A metalloprotease activity from C6 cells inactivates the myelin-associated neurite growth inhibitors and can be neutralized by antibodies. Br. Cancer J. 78:1564-1572.
16. Hoffman, S., B.C. Sorkin, P.C. White, R. Brackenbury, R. Mailhammer, U. Rutishauser, B. A. Cunningham, and G.M. Edelman. 1982. Chemical characterization of a neural cell adhesion molecule purified from embryonic brain membranes. J. Biol. Chem. 257:7720-7729.
17. Huber, A.B., M.S. Chen, M.E. Van Der Haar, and M.E. Schwab. 1998. Developmental expression pattern and functional analysis of Nogo (formarly NI-35/250), a major inhibitor of CNS regeneration. Soc. Neurosci. Abstr. 24: 1559.
18. Imai, K., E. Ohuchi, T. Aoki, H. Nomura, Y. Fujii, H. Sato, M. Seiki, and Y. Okada. 1996. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinase 2. Cancer Res. 56:2707-2710.
19. Itoh, T., M. Tanioka, H. Yoshida, T. Yoshioka, H. Nishimoto, and S. Itohara. 1998. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58:1048-1051.
20. Kleihues, P., and W.K. Cavenee. 1997. Pathology and genetics of tumours of the nervous system. IARC. 56:1-9.
21. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophages. Nature. 227:680-685.
22. Laerum, O.D., R. Bjerkvig, S.K. Steinsvag, and L. De Ridder. 1984. Invasiveness of primary brain tumors. Cancer Met. Rev. 3:223-236.
23. Nagase, H. 1997. Activation mechanism of matrix metalloproteases. Biol. Chem. 378:151-160.
24. Nakahara, H., L. Howard, E.W. Thompson, H. Sato, M. Seiki. Y.Y. Yeh, and W.T. Chen. 1997. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc. Natl. Acad. Sci. USA. 94:7959-7964.
25. Ohtani, H., H. Motohashi, H. Sato, M. Seiki, and H. Nagura. 1996. Dual over-expression of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy. Int. J. Cancer. 68:565-570.
26. Ohuchi, E., K. Imai, Y. Fuji, H. Sato, M. Seiki, and Y. Okada. 1997. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272:2446-2451.
27. Okada, A., J.P. Bellocq, N. Rouyer, M.P. Chenard, M.C. Rio, P. Chambon, and P. Basset. 1995. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA. 92:2730-2734.
28. d'Ortho, M.P., H. Will, S. Atkinson, G. Butler, A. Messent, J. Gavrilovic, B. Smith, R. Timpl, L. Zardi, and G. Murphy. 1997. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250:751-757.
29. d'Ortho, M.P., H. Stanton, M. Butler, S.J. Atkinson, G. Murphy, R.M. Hembry. 1998. MT1-MMP on the cell surface causes focal degradation of gelatin films. FEBS (Fed Eur. Biochem Soc.) Lett. 421:159-164.
30. Paganetti, P.A., P. Caroni, and M.E. Schwab. 1988. Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease. J. Cell Biol. 107:2281-2291.
31. Pedersen, P.H., K. Edvardsen, I. Garcia-Cabrera, R. Mahesparan. J. Thorson, B. Mathisen, M.L. Rosenblum, and R. Bjerkvig. 1995. Migratory patterns of lac-z transfected human glioma cells in the rat brain. Int. J. Cancer. 62:767-771.
32. Pei, D., and S.J. Weiss. 1996. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271:9135-9140.
33. Pilkington, G.J. 1994. Tumour cell migration in the central nervous system. Brain Pathol. 4:157-166.
34. Polette, M., B. Nawrocki, C. Gilles, H. Sato, M. Seiki, J.M. Tournier, and P. Birembaut. 1996. MT1-MMP expression and localisation in human lung and breast cancers. Virchows Arch. 428:29-35.
35. Rodgers, W.H., L.M. Matrisian, L.C. Guidice, B. Dsupin, P. Cannon, C. Svitek, F. Gorstein, and K.G. Osteen. 1994. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J. Clin. Invest. 94:946-953.
36. Rooprai, H.K., and D. McCormick. 1997. Proteases and their inhibitors in human brain tumours: a review. Anticancer Res. 17:4151-4162.
37. Ruat, M., M.E. Molliver, A.M. Snowman, and S.H. Snyder. 1995. Calcium sensing receptor: molecular cloning in rat and localization to nerve terminals. Proc. Natl. Acad. Sci. USA. 92:3161-3165.
38. Sato, H., T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. Seiki. 1994. A matrix matalloproteinase expressed on the surface of invasive tumour cells. Nature. 370:61-65.
39. Sato, H., and M. Seiki. 1996a. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J. Biochem. 119:209-215.
40. Sato, H., T. Kinoshita, T. Takino, K. Nakayama, and M. Seiki. 1996b. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS (Fed. Eur. Biochem. Soc.) Lett. 393:101-104.
41. Sawaya, R.E., M. Yamamoto, Z.L. Gokaslan, S.W. Wang, S. Mohanam, G.N. Fuller, I.E. McCutcheon, W.G. Stetler-Stevenson, G.L. Nicolson, and J.S. Rao. 1996. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin. Exp. Met. 14:35-42.
42. Schwab, M.E., and H. Thoenen. 1985. Dissociated neurons regenerate into sciatic but not optic nerve explants in culture irrespective of neurotrophic factors. J. Neurosci. 5:2415-2423.
43. Schwab, M.E., and P. Caroni. 1988. Oligodendrocytes and CNS myelin are non-permissive substrates for neurite growth and fibroblast spreading in vitro. J. Neurosci. 8:2381-2393.
44. Spillmann, A.A., V.R. Amberger, and M.E. Schwab. 1997. High molecular weight protein of human central nervous system inhibits neurite outgrowth: an effect which can be neutralized by the monoclonal antibody IN-1. Eur. J. Neurosci. 9:549-555.
45. Spillmann, A.A., C.E. Bandtlow, F. Lottspeich, F. Keller, and M.E. Schwab. 1998. Identification and characterization of a bovine neurite growth inhibitor (bN1-220). J. Biol. Chem. 273:19283-19293.
46. Strongin, A.Y., B.L. Marmer, G.A. Grant, and G.I. Goldberg. 1993. Plasma membrane-dependent activation of the 72-kDa Type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem. 268:14033-14039.
47. Stuve, O., N.P. Dooley, J.H. Uhm, J.P. Antel, G.S. Francis. G. Williams, and V.W. Yong. 1996. Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann. Neurol. 40:853-863.
48. Tokuraka, M., H. Sato, S. Murakami, Y. Okada. Y. Watanabe, and M. Seiki. 1995. Activation of the precursor of gelatinase A/72 kDa typeIV collagenase/MMP-2 in lung carcinomas correlated with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int. J. Cancer. 64:355-359.
49. Uhm, J.H., N.P. Dooley, J.-G. Villemure, and V.W. Yong. 1996. Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. Clin. Exp. Met. 14:421-433.
50. Uhm, J.H., N.P. Dooley, J.-G. Villemure, and V.W. Yong. 1997. Mechanisms of glioma invasion: role of matrix-metalloproteinases. Cancer J. Neurol. Sci. 24: 3-15.
51. Wojtowicz-Praga, S.M., R.B. Dickson, and M.J. Hawkins. 1997. Matrix metalloproteinase inhibitors. Invest. New Drugs. 15:61-75.
52. Yamada, Y., Y. Yoshiyama, H. Sato, M. Seiki, A. Shinagawa, and M. Takahashi. 1995. White matter microglia produce membrane-type matrix metalloprotease, an activator of gelatinase A, in human brain tissue. Acta Neuropathol. 90:421-424.
53. Yamamoto, M., S. Mohanam, R. Sawaya, G.N. Fuller, M. Seiki, H. Sato, Z.L. Gokaslan, L. A. Liotta, G.L. Nickolson, and J.S. Rao. 1996. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelalinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res. 56:384-392.
54. Yoshizaki, T., H. Sato, Y. Maruyama, S. Murono, M. Furukawa, C.S. Park, and M. Seiki. 1997. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer. 79:139-144.